Methods and compositions for assessing and treating emetogenic drug-related nausea

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11761949
APP PUB NO 20190317114A1
SERIAL NO

16340615

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for assessing susceptibility to nausea of a patient comprises assessing the GSH recycling dependent antioxidant activity of the patient's blood cells prior to receiving an emetogenic agent, e.g., a cytostatic agent or a surgical anesthetic.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LANKENAU INSTITUTE FOR MEDICAL RESEARCH100 LANCASTER AVENUE WYNNEWOOD PA 19096

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Wallon, Margaretha Ardmore, US 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 19, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 19, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 19, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00